GSK-3β inhibitors are currently being utilized for the treatment of various diseases including Alzheimer's disease [113, 114] and other neurodegenerative diseases [18], diabetes, inflammatory disorders [115], radiation damage, and cancer [116]. The gene discussed is GSK3B; the disease is Alzheimer disease.